These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 21173347)
1. Finding pieces of the puzzle of nonresponse to cardiac resynchronization therapy. Gorcsan J Circulation; 2011 Jan; 123(1):10-2. PubMed ID: 21173347 [No Abstract] [Full Text] [Related]
2. Cardiac resynchronization therapy for mild heart failure: the time has come. Reynolds CR; Gold MR Circulation; 2011 Jan; 123(2):195-202. PubMed ID: 21242505 [No Abstract] [Full Text] [Related]
3. Cardiac resynchronization therapy in patients with class I-II heart failure and a wide QRS: a cautionary note. Tang WH; Francis GS Circulation; 2011 Jan; 123(2):203-8. PubMed ID: 21242506 [No Abstract] [Full Text] [Related]
5. Lessons learned from clinical trials in acute heart failure: phase 3 drug trials. O'Connor CM; Fiuzat M Heart Fail Clin; 2011 Oct; 7(4):451-6. PubMed ID: 21925428 [TBL] [Abstract][Full Text] [Related]
6. Cardiac resynchronization therapy in the elderly: a realistic option for an increasing population? António N; Elvas L; Gonçalves L; Providência LA Int J Cardiol; 2012 Feb; 155(1):49-51. PubMed ID: 21334076 [TBL] [Abstract][Full Text] [Related]
7. [ Upgrading of cardiac resynchronization therapy devices in patients with heart failure--uprising clinical problem. ]. Przybylski A Kardiol Pol; 2010 Nov; 68(11):1242. PubMed ID: 21108201 [No Abstract] [Full Text] [Related]
8. A review of phase II acute heart failure syndromes clinical trials. Pang PS; Gheorghiade M Heart Fail Clin; 2011 Oct; 7(4):441-50. PubMed ID: 21925427 [TBL] [Abstract][Full Text] [Related]
9. Clinical and prognostic role of pressure-volume relationship in the identification of responders to cardiac resynchronization therapy. Ciampi Q; Pratali L; Citro R; Villari B; Picano E; Sicari R Am Heart J; 2010 Nov; 160(5):906-14. PubMed ID: 21095279 [TBL] [Abstract][Full Text] [Related]
10. Cardiac contractility modulation: the next cardiac resynchronization therapy or another renal sympathetic denervation? Mentz RJ; Butler J J Card Fail; 2015 Jan; 21(1):24-6. PubMed ID: 25463742 [No Abstract] [Full Text] [Related]
11. Echocardiographic mapping of left ventricular resynchronization during cardiac resynchronization therapy procedures. Chan NY; Choy CC; Cheung KC; Lau CL; Lo YK; Chu PS; Yuen HC; Lau ST; Choi YC Chin Med J (Engl); 2010 Jul; 123(13):1645-51. PubMed ID: 20819622 [TBL] [Abstract][Full Text] [Related]
12. Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapy. Delgado V; van Bommel RJ; Bertini M; Borleffs CJ; Marsan NA; Arnold CT; Nucifora G; van de Veire NR; Ypenburg C; Boersma E; Holman ER; Schalij MJ; Bax JJ Circulation; 2011 Jan; 123(1):70-8. PubMed ID: 21173353 [TBL] [Abstract][Full Text] [Related]
13. "Advantage of optimizing V-V timing in cardiac resynchronization therapy devices" by Dr. Duvall. Geng J; Zhu J Pacing Clin Electrophysiol; 2010 Oct; 33(10):1289-90; author reply 1290-1. PubMed ID: 20718923 [No Abstract] [Full Text] [Related]
14. Cardiac resynchronisation therapy for heart failure with narrow or normal QRS. Yip GW; Fung JW Heart; 2011 Jul; 97(13):1029-31. PubMed ID: 21343170 [No Abstract] [Full Text] [Related]